OHSU Biotech Spinoff Takes Long Step Toward Commercial Viability
April 16, 2007
ProteoGenix, an Oregon Health & Science University spinoff company which has developed a test that could displace amniocentesis — the only procedure now available for diagnosing intra-amniotic infection — has taken a long step toward commercial ...